Literature DB >> 24420861

Rapamycin inhibition of CFA-induced lymphangiogenesis in PLN is independent of mast cells.

Rui-Cheng Ji1, Yuki Eshita.   

Abstract

Elucidation of the events responsible for the interaction between lymphatic endothelial cells (LECs) and mast cells (MCs) may prove to be a valuable source for controlling lymphangiogenesis. In the present study, we compared immunohistochemical and RT-PCR findings of the popliteal lymph node (PLN) and footpad skin in C57BL/6J and WBB6F1 mice, the MC-deficient strain. The results indicated that MCs play certain role in complete Freund's adjuvant-induced intranodal lymphangiogenesis. VEGF-A, VEGFR-2 and TNF-α were crucial factors in lymphangiogenesis both in the PLN and skin. Moreover, the in vivo administration of the specific mTOR inhibitor, rapamycin inhibited lymphangiogenesis independent of MCs in PLN rather than in the skin. Further study on anti-lymphangiogenic effect will contribute to our understanding of LEC and MC modulation in pathological lymphangiogenesis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24420861     DOI: 10.1007/s11033-014-3073-1

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  25 in total

Review 1.  Mast cell modulation of the vascular and lymphatic endothelium.

Authors:  Christian A Kunder; Ashley L St John; Soman N Abraham
Journal:  Blood       Date:  2011-09-08       Impact factor: 22.113

2.  Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor.

Authors:  Markus Guba; Philipp von Breitenbuch; Markus Steinbauer; Gudrun Koehl; Stefanie Flegel; Matthias Hornung; Christiane J Bruns; Carl Zuelke; Stefan Farkas; Matthias Anthuber; Karl-Walter Jauch; Edward K Geissler
Journal:  Nat Med       Date:  2002-02       Impact factor: 53.440

3.  VEGF-D promotes tumor metastasis by regulating prostaglandins produced by the collecting lymphatic endothelium.

Authors:  Tara Karnezis; Ramin Shayan; Carol Caesar; Sally Roufail; Nicole C Harris; Kathryn Ardipradja; You Fang Zhang; Steven P Williams; Rae H Farnsworth; Ming G Chai; Thusitha W T Rupasinghe; Dedreia L Tull; Megan E Baldwin; Erica K Sloan; Stephen B Fox; Marc G Achen; Steven A Stacker
Journal:  Cancer Cell       Date:  2012-02-14       Impact factor: 31.743

4.  Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3.

Authors:  T Mäkinen; T Veikkola; S Mustjoki; T Karpanen; B Catimel; E C Nice; L Wise; A Mercer; H Kowalski; D Kerjaschki; S A Stacker; M G Achen; K Alitalo
Journal:  EMBO J       Date:  2001-09-03       Impact factor: 11.598

5.  Inhibition of the mammalian target of rapamycin impedes lymphangiogenesis.

Authors:  S Huber; C J Bruns; G Schmid; P C Hermann; C Conrad; H Niess; R Huss; C Graeb; K-W Jauch; C Heeschen; M Guba
Journal:  Kidney Int       Date:  2007-02-14       Impact factor: 10.612

6.  Direct recruitment of CRK and GRB2 to VEGFR-3 induces proliferation, migration, and survival of endothelial cells through the activation of ERK, AKT, and JNK pathways.

Authors:  Ahmad Salameh; Federico Galvagni; Monia Bardelli; Federico Bussolino; Salvatore Oliviero
Journal:  Blood       Date:  2005-08-02       Impact factor: 22.113

7.  Stimulation of protein synthesis, eukaryotic translation initiation factor 4E phosphorylation, and PHAS-I phosphorylation by insulin requires insulin receptor substrate 1 and phosphatidylinositol 3-kinase.

Authors:  R Mèndez; M G Myers; M F White; R E Rhoads
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

8.  Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors.

Authors:  Laura Soucek; Elizabeth R Lawlor; Darya Soto; Ksenya Shchors; Lamorna Brown Swigart; Gerard I Evan
Journal:  Nat Med       Date:  2007-09-30       Impact factor: 53.440

9.  Rapamycin, a specific inhibitor of the mammalian target of rapamycin, suppresses lymphangiogenesis and lymphatic metastasis.

Authors:  Soichi Kobayashi; Takashi Kishimoto; Shigeyuki Kamata; Masayuki Otsuka; Masaru Miyazaki; Hiroshi Ishikura
Journal:  Cancer Sci       Date:  2007-05       Impact factor: 6.716

Review 10.  The roles of mast cells in anticancer immunity.

Authors:  Dyana K Dalton; Randolph J Noelle
Journal:  Cancer Immunol Immunother       Date:  2012-04-18       Impact factor: 6.968

View more
  3 in total

1.  Role of simvastatin in tumor lymphangiogenesis and lymph node metastasis.

Authors:  Rui-Cheng Ji; Yuki Eshita; Takashi Kobayashi; Shinya Hidano; Naganori Kamiyama; Yasuhiko Onishi
Journal:  Clin Exp Metastasis       Date:  2018-09-25       Impact factor: 5.150

Review 2.  Lymph Nodes and Cancer Metastasis: New Perspectives on the Role of Intranodal Lymphatic Sinuses.

Authors:  Rui-Cheng Ji
Journal:  Int J Mol Sci       Date:  2016-12-28       Impact factor: 5.923

Review 3.  The role of lymphangiogenesis in cardiovascular diseases and heart transplantation.

Authors:  Rui-Cheng Ji
Journal:  Heart Fail Rev       Date:  2021-11-04       Impact factor: 4.654

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.